![](../../files/images/goods/1798310-55-0.png)
AR420626
CAS No. 1798310-55-0
AR420626 ( AR-420626 | AR 420626 | AR420626 )
产品货号. M27851 CAS No. 1798310-55-0
AR420626 是一种选择性脂肪酸 3 受体 (FA3R) 激动剂,可提供针对 Salsolionl (SALS) 的保护作用,而 SALS 则可被选择性 FA3R 拮抗剂 β-羟基丁酸酯 (BHB) 完全阻断。
纯度: >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥583 | 有现货 |
![]() ![]() |
10MG | ¥988 | 有现货 |
![]() ![]() |
25MG | ¥2203 | 有现货 |
![]() ![]() |
50MG | ¥3548 | 有现货 |
![]() ![]() |
100MG | ¥5257 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称AR420626
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述AR420626 是一种选择性脂肪酸 3 受体 (FA3R) 激动剂,可提供针对 Salsolionl (SALS) 的保护作用,而 SALS 则可被选择性 FA3R 拮抗剂 β-羟基丁酸酯 (BHB) 完全阻断。
-
产品描述AR420626 is a selective fatty acid 3 receptor (FA3R) agonist and provides protective effects against salsolionl (SALS), which was totally blocked by beta-hydroxy butyrate (BHB), a selective FA3R antagonist.
-
体外实验——
-
体内实验——
-
同义词AR-420626 | AR 420626 | AR420626
-
通路Others
-
靶点Other Targets
-
受体PKMYT1
-
研究领域——
-
适应症——
化学信息
-
CAS Number1798310-55-0
-
分子量417.29
-
分子式C21H18Cl2N2O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 20 mg/mL (47.93 mM)
-
SMILESCC1=C(C(c2ccco2)C2=C(CCCC2=O)N1)C(=O)Nc1cc(Cl)ccc1Cl
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Charlott Platzer,et al. Identification of PKMYT1 inhibitors by screening the GSK published protein kinase inhibitor set I and II. Bioorg Med Chem. 2018 Aug 7;26(14):4014-4024.
产品手册
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/new12.jpg)
![](/themes/theme/en/images/gift.jpg)
![](/themes/theme/en/images/ct2.png)
关联产品
-
9-Methyl-9H-beta-car...
The herbs of Rauvolfia verticillata.
-
3,5-Diiodo-L-tyrosin...
3,5-二碘-L-酪氨酸二水合物是一种天然产物。
-
Hellebrigenol
Hellebrigenol shows cytotoxicity against HepG2 cells.